Search
for
Sort by
Research 61–90 of 1000+
- Synthesis and in Vitro Evaluation of 4-Substituted N-(1,1-Dimethylethyl)-3-oxo-4-androstene-17.beta.-carboxamides as 5.alpha.-Reductase Inhibitors and Antiandrogens
- Pharmacophore and Atom Based 3D QSAR Studies on the Novel 5-Alpha-Reductase Inhibitors
- Synthesis and Structure–Activity Relationships of the First Ferrocenyl-Aryl-Hydantoin Derivatives of the Nonsteroidal Antiandrogen Nilutamide
- Management of Cutaneous and Extracutaneous Side Effects of Smoothened Inhibitor Therapy for Advanced Basal Cell Carcinoma
- A new label-free screen for steroid 5α-reductase inhibitors using LC-MS
- Repurposing steroidogenesis inhibitors for the therapy of neuropsychiatric disorders: Promises and caveats
- Phosphodiesterase inhibitors and prostaglandin analogues in dermatology: A comprehensive review
- 277 An open label pilot clinical trial of the JAK inhibitor tofacitinib for alopecia areata
- Evaluation of dermatologic adverse events associated with aromatase inhibitors: insights from the FAERS database
- Janus Kinase inhibitors in dermatology: a review
- Biologic Therapies and Small-Molecule Inhibitors for Dissecting Cellulitis of the Scalp: A Systematic Review
- Computational Evaluation of Dibenzo Compounds as Potential Dual Inhibitors of Androgen Receptor and 5α-Reductase
- 5α- Reductase Inhibitors in Prostate Cancer: An Overview
- Synthesis of Spiro[cyclohexane-1,2?-[2H]indene] derivatives as inhibitors of steroid 5?-reductase
- Non polycystic ovary syndrome–related endocrine disorders associated with hirsutism
- Tumor necrosis factor inhibitors and janus kinase inhibitors in the treatment of cicatricial alopecia: A systematic review
- 711 Small molecule wnt pathway inhibitor (SM04755) as a potential topical psoriasis treatment
- Synthesis and activity of 8-substituted benzo[c]quinolizin-3-ones as dual inhibitors of human 5α-reductases 1 and 2
- Clinical use of 5α-reductase inhibitors
- 5α-Reductase Inhibitors, Chemical and Clinical Models
- Effect of Testosterone Supplementation With and Without a Dual 5α-Reductase Inhibitor on Fat-Free Mass in Men With Suppressed Testosterone Production
- Cutaneous effects of the most commonly used antidepressant medication, the selective serotonin reuptake inhibitors
- New 5?-reductase inhibitors: In vitro and in vivo effects
- Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men
- 12 Treatment of hirsutism with 5α-reductase inhibitors
- Inhibitors of 5α -Reductase Type I in LNCaP Cells from the Roots of Angelica koreana
- FCE 28260, a new 5α-reductase inhibitor: In vitro and in vivo effects
- COMBINATION OF AN ANTIANDROGEN AND A 5α-REDUCTASE INHIBITOR: A FURTHER STEP TOWARDS TOTAL ANDROGEN BLOCKADE?
- Hormone receptor positive, HER2 negative metastatic breast cancer: Impact of CDK4/6 inhibitors on the current treatment paradigm
- New Progesterone Esters as 5.ALPHA.-Reductase Inhibitors.